V7 Diagnostic Ultrasound System vs syngo MBF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Samsung Medison Co.
VS
by Siemens Medical Solutions USA, Inc.

AI Verdict

Tool A, the Samsung V7, is a versatile diagnostic ultrasound system offering AI for various applications including women's health, general imaging, and cardiovascular. Tool B, syngo MBF, is an AI-enhanced software specifically for quantitative myocardial blood flow analysis using PET imaging. While both have cardiology AI applications, their fundamental imaging modalities (ultrasound vs. PET) and broader scopes differ significantly, making them adjacent rather than direct competitors.

Choose V7 Diagnostic Ultrasound System if…

Choose the Samsung V7 Diagnostic Ultrasound System if your practice requires a versatile, high-performance ultrasound solution for a broad range of applications, particularly in women's health, general imaging, and cardiovascular assessments. Its AI-powered features like BiometryAssist™ and UterineAssist™ are ideal for automating measurements and enhancing diagnostic precision in obstetrics and gynecology, while S-Shearwave Imaging™ offers quantitative tissue stiffness assessment for areas like the breast and liver.

View V7 Diagnostic Ultrasound System →

Choose syngo MBF if…

Choose syngo MBF if your cardiology or nuclear medicine department specializes in quantitative myocardial blood flow analysis using PET imaging. This AI-enhanced software, integrated within the syngo.via platform, is specifically designed for precise calculation of Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) using dynamic Rubidium-PET and Ammonia-PET images, offering advanced tools for cardiac diagnostics and therapy response assessment.

View syngo MBF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature V7 Diagnostic Ultrasound System syngo MBF
Pricing Contact for pricing Contact vendor
Deployment On-premise (hardware) On-premise (dedicated hardware), Virtualized environments (VMware, Hyper-V)
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

V7 Diagnostic Ultrasound System

The Samsung V7 emphasizes a re-engineered design for workflow, performance, and functionality, with tools like EzExam+ and EzCompare minimizing steps and keystrokes. User testimonials also highlight its intuitive operation. In contrast, syngo MBF, while integrated into the syngo.via platform which aims for a consistent user experience, is a specialized software that requires installation onto a pre-existing syngo.via platform, suggesting a potentially more complex setup and integration process.

Clinical Value

V7 Diagnostic Ultrasound System

Both tools offer significant clinical value in their respective domains. However, the Samsung V7 covers a broader range of applications including women's health, general imaging, and cardiovascular, with numerous AI-powered intelligent assist features for diagnostic precision across these specialties. syngo MBF is highly specialized for quantitative myocardial blood flow analysis using PET imaging, which is crucial for cardiac diagnostics, but its scope is narrower.

Pricing & Value

Tie

Both companies state 'contact for pricing' or 'contact vendor,' indicating a lack of transparent, publicly available pricing. While some third-party sites list prices for the V7, these appear to be regional or reseller specific and not official. Without direct pricing information or detailed value propositions from both vendors, it's impossible to definitively determine which offers better pricing or overall value.

Enterprise Readiness

syngo MBF

syngo MBF is integrated within Siemens' syngo.via platform, which is designed as an integrated multimodality imaging solution for enterprise-wide systems, offering scalability and flexible deployment options including virtualized environments. The Samsung V7 is an on-premise hardware system, which, while high-performance, may present more traditional challenges for large-scale enterprise deployment and integration compared to a software-centric platform.

Innovation

V7 Diagnostic Ultrasound System

The Samsung V7 showcases a wide array of AI-powered intelligent assist features for diverse applications like automated fetal biometry, fetal heart evaluation, and uterine measurements, alongside advanced imaging architecture. While syngo MBF utilizes AI for quantitative myocardial blood flow analysis and leverages the ALPHA technology within syngo.via for workflow acceleration, the V7's broader and more numerous AI-driven diagnostic and workflow enhancements suggest a greater breadth of innovation in its core product offering.

Support & Docs

syngo MBF

Siemens Healthineers offers a comprehensive support ecosystem for syngo.via, including a dedicated user forum and extensive online resources for product downloads, knowledgebase articles, and self-paced learning materials. Samsung provides warranty information, replacement parts, and various contact methods for support, including online chat and service centers. However, the structured community and educational resources offered by Siemens appear more robust for ongoing user support and knowledge sharing.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature V7 Diagnostic Ultrasound System syngo MBF
Tool Name V7 Diagnostic Ultrasound System syngo MBF
Company Samsung Medison Co. Siemens Medical Solutions USA, Inc.
Description The Samsung V7 Diagnostic Ultrasound System is a high-performance, versatile ultrasound scanner featuring AI-powered tools and advanced imaging technology for superior diagnostic capabilities across women's health, general imaging, and cardiovascular applications. syngo MBF by Siemens Medical Solutions USA, Inc. is an FDA-cleared, AI-enhanced software for quantitative myocardial blood flow (MBF) analysis using PET imaging. Integrated within the syngo.via platform, it provides advanced tools for cardiac diagnostics and therapy response assessment.
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Nuclear Medicine, Radiology
Key Features (Examples) Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122) for enhanced 2D, 3D, and color imaging, AI-Powered Intelligent Assist features for diagnostic precision and workflow efficiency, BiometryAssistu2122 for automated fetal biometry measurements Quantitative Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) calculation, Supports dynamic Rubidium-PET and Ammonia-PET images, Automatic and manual myocardium orientation and segmentation tools

Videos

Demos, reviews, and walkthroughs featuring V7 Diagnostic Ultrasound System and syngo MBF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Samsung V7 Diagnostic Ultrasound System is designed with an intuitive and ergonomic interface, including features like EzExam+u2122 and EzCompareu2122 to streamline workflow and minimize keystrokes, making it easy to use in busy environments. syngo MBF, integrated within the syngo.via platform, is designed to orchestrate imaging workflows from acquisition to reading and sharing, with cases instantly available from virtually anywhere, including PACS, and can export reports as HL7 messages or DICOM encapsulated PDFs.
The Samsung V7 utilizes Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122) for enhanced 2D, 3D, and color imaging, and includes AI-powered features like BiometryAssistu2122 for automated fetal measurements and S-Shearwave Imagingu2122 for quantitative tissue stiffness assessment, aiming for diagnostic precision and accuracy. syngo MBF provides quantitative myocardial blood flow (MBF) and myocardial flow reserve (MFR) calculations, and studies have shown excellent concordance for MBF and MFR values between syngo.PET (which includes syngo MBF) and other software packages, despite some variations in absolute values.
The Samsung V7 is designed with a user-friendly interface, including a customizable touchscreen (TouchEdit) and streamlined controls, to make it intuitive and easy to navigate, suggesting a potentially shorter learning curve. While specific details on syngo MBF's learning curve are not provided, its integration into the syngo.via platform, which aims to simplify routine tasks and provide intelligent tools for a more productive diagnostic workflow, suggests an emphasis on usability.
syngo MBF, as part of the syngo.via platform, incorporates system protection measures to prevent data theft and comply with changing security guidelines, including user authentication, restricted access to functions and data through privileges, and audit trails to record user and system activities. Information regarding specific security features beyond HIPAA for the Samsung V7 is not detailed in the provided information.
syngo MBF, integrated into the syngo.via platform, includes audit trails to record user and system activities, ensuring accountability and tracking of data access. The provided information for the Samsung V7 Diagnostic Ultrasound System does not explicitly mention audit-trail features.
The Samsung V7 is a hardware-based ultrasound system, implying that multi-site rollouts would involve the physical deployment of each unit. syngo MBF, as a software solution integrated with the syngo.via platform, is designed for flexibility and scalability, supporting multi-site environments and allowing for a common syngo.via server to be shared across departments.
The Samsung V7 offers distinct advantages in women's health, general imaging, and cardiovascular applications, with AI tools like BiometryAssistu2122 for fetal measurements, UterineAssistu2122 for automated uterine analysis, and 5D Heart Coloru2122 for fetal heart evaluation, making it highly versatile for diverse ultrasound needs. syngo MBF provides a distinct advantage for highly specialized, AI-enhanced quantitative myocardial blood flow and myocardial flow reserve analysis using PET imaging, which is crucial for in-depth cardiac diagnostics and assessing myocardial perfusion.
AI Tool Finder
AI-powered search. Results may not be comprehensive.